Description
An active metabolite of tolterodine and fesoterodine; inhibits M1-5 muscarinic receptors (Kis = 2.3, 2, 2.5, 2.8, and 2.9 nM, respectively); selectively inhibits acetylcholine-induced bladder contraction over electrically induced salivation in anesthetized cats (ID50s = 15 and 40 nmol/kg, respectively)
Formal name: formic acid, compd. with 3-[(1R)-3-[bis(1-methylethyl)amino]-1-phenylpropyl]-4-hydroxybenzenemethanol
Synonyms: 5-HMT|Desfesoterodine|PNU 200577
Molecular weight: 387.5
CAS: 380636-49-7
Purity: ≥98%
Formulation: A solid
Product Type|Biochemicals|Receptor Pharmacology|Antagonists||Product Type|Biochemicals|Xenobiotic Metabolites||Research Area|Toxicology|Drug Metabolism|Cytochrome P450||Research Area|Toxicology|Drug Metabolism|Drug Metabolites